Two Sigma Securities’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,140
Closed -$625K 3750
2023
Q3
$625K Buy
3,140
+1,668
+113% +$394K 0.01% 1367
2023
Q2
$420K Buy
1,472
+114
+8% +$31.7K 0.01% 1568
2023
Q1
$294K Sell
1,358
-1,101
-45% -$215K 0.01% 1728
2022
Q4
$506K Buy
2,459
+1,454
+145% +$368K 0.02% 1078
2022
Q3
$279K Buy
+1,005
New +$256K 0.01% 1650
2022
Q1
Sell
-1,186
Closed -$211K 2620
2021
Q4
$211K Buy
+1,186
New +$234K 0.01% 1053
2021
Q3
Sell
-1,267
Closed -$240K 2049
2021
Q2
$240K Buy
+1,267
New +$207K 0.01% 1165
2021
Q1
Sell
-3,805
Closed -$395K 1896
2020
Q4
$395K Buy
+3,805
New +$330K 0.01% 844

Other funds holding SWAV

Two Sigma Securities's SWAV Position: Q4 2023 in Review

Two Sigma Securities sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 3,140 shares — an estimated $625K sold.

Two Sigma Securities first reported a position in SWAV in Q4 2020 and held it in 8 quarters. The position peaked at $625K in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Two Sigma Securities reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 3,140 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $625K.
  • Two Sigma Securities first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Two Sigma Securities's Shockwave Medical, Inc. Common Stock position peaked at $625K in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.